Valuation : Becton, Dickinson and Company

Market Cap 4.84TCr 4.17TCr 3.95TCr 3.58TCr 6.72TCr 4,62800Cr 6.75TCr 47TCr 18TCr 2,35500Cr 18TCr 18TCr 7,44000Cr P/E 2026 *
34.3x
P/E 2027 * 19.1x
Enterprise Value 6.43TCr 5.54TCr 5.25TCr 4.76TCr 8.92TCr 6,14600Cr 8.97TCr 62TCr 24TCr 3,12700Cr 24TCr 24TCr 9,88000Cr EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.17x
Free-Float
73.18%
Yield 2026 *
2.21%
Yield 2027 * 2.24%
1 day+0.46%
1 week-5.20%
Current month-6.34%
1 month-2.78%
3 months+18.04%
6 months+9.22%
Current year-8.09%
1 week 151.45
Extreme 151.45
157.5
1 month 151.45
Extreme 151.45
163.9
Current year 121
Extreme 121
179
1 year 121
Extreme 121
179
3 years 121
Extreme 121
253.5
5 years 121
Extreme 121
265
10 years 121
Extreme 121
265
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%-5.20% - - 4.84TCr
-1.36%-5.89%-23.76%-0.44% 18TCr
-0.72%-3.41%-3.26%+12.32% 12TCr
+0.19%-2.83%+6.30%+80.17% 6.14TCr
-1.92%-6.01%+7.05%+38.44% 4.94TCr
+0.81%-3.73%-4.81%-32.56% 4.84TCr
-1.75%-5.54%+8.93%-20.82% 3.13TCr
+0.43%-11.10% - - 2.85TCr
+0.58%+1.84%+36.58%-12.08% 2.44TCr
+0.49%-7.65%-13.30%+3.79% 2.16TCr
Average -0.28%-5.08%+1.72%+8.60% 6.2TCr
Weighted average by Cap. -0.60%-4.90%-6.02%+10.83%

Financials

2026 *2027 *
Net sales 1.93TCr 1.66TCr 1.57TCr 1.42TCr 2.67TCr 1,84000Cr 2.69TCr 19TCr 7.18TCr 94TCr 7.23TCr 7.07TCr 2,95800Cr 1.97TCr 1.7TCr 1.61TCr 1.46TCr 2.73TCr 1,88100Cr 2.75TCr 19TCr 7.34TCr 96TCr 7.39TCr 7.23TCr 3,02400Cr
Net income 143.66Cr 123.78Cr 117.2Cr 106.23Cr 199.3Cr 14TCr 200.31Cr 1.39TCr 535.29Cr 6.98TCr 539.54Cr 527.7Cr 22TCr 233.95Cr 201.57Cr 190.86Cr 173Cr 324.55Cr 22TCr 326.2Cr 2.27TCr 871.7Cr 11TCr 878.62Cr 859.35Cr 36TCr
Net Debt 1.59TCr 1.37TCr 1.3TCr 1.17TCr 2.2TCr 1,51800Cr 2.21TCr 15TCr 5.92TCr 77TCr 5.97TCr 5.83TCr 2,44000Cr 1.4TCr 1.2TCr 1.14TCr 1.03TCr 1.94TCr 1,33300Cr 1.95TCr 14TCr 5.2TCr 68TCr 5.24TCr 5.12TCr 2,14300Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
11/26/11 €152.15 +0.46% 0
10/26/10 €151.45 -2.13% 10
09/26/09 €154.75 -0.23% 80
08/26/08 €155.10 -1.52% 20
07/26/07 €157.50 -1.87% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
177.85USD
Average target price
195.67USD
Spread / Average Target
+10.02%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!